| 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 |
|
| |
New and Competitively Renewed
Peer-Reviewed Awards Received in 2019
|
|
| Dr. Julian Abrams |
|
|
1-year AGA-Elsevier Pilot Research Award, AGA Research Foundation
“Enterobacteriaceae and Progression to Esophageal Adenocarcinoma” |
|
|
5-year new R01, NIH/NCI
“The Oral Microbiome for the Detection of Barretts Esophagus” |
|
|
|
| Dr. Marwah Abdalla |
|
|
5-year Mentored Patient-Oriented Research Career Development Award (K23), NIH/NHLBI
“Nocturnal Hypertension and Sleep” |
|
|
|
| Dr. Melissa Accordino |
|
|
2-year Small Grant (R03), NIH/NCI
“Cryotherapy and Compression Therapy to Prevent Chemotherapy Induced Peripheral Neuropathy in Breast Cancer Patients” |
|
|
|
| Dr. Rajat Bansal (mentor: Dr. Ran Reshef) |
|
|
1-year Hayden Family Foundation Young Investigator Award, American Society of Clinical Oncology (ASCO)/Conquer Cancer Foundation
“Phase II, Single Arm, Open Label Study to Assess the Efficacy of GLP-2 Agonist ZP1846 in the Prevention of Melphalan Induced Diarrhea among Bone Marrow Transplant Patients” |
|
|
|
| Dr. R. Graham Barr |
|
|
[Multiple PI award with Dr. Andrew Laine (Dept. of Biomedical Engineering)]
4-year R01 competitive renewal, NIH/NHLBI
“Novel Quantitative Emphysema Subtypes in MESA and SPIROMICS” |
|
|
4-year R01 competitive renewal, NIH/NHLBI
“Combined Cardiopulmonary Failure in COPD: SPIROMICS HF” |
|
|
|
| Drs. R. Graham Barr, David Lederer, Neil Schluger |
|
|
5-year Institutional Research Training Grant (T32), NIH/NHLBI
“Training Program in Population Science of Respiratory Diseases” |
|
|
|
| Dr. Jeremy Beitler |
|
|
2-year Exploratory/Developmental Research Grant (R21), NIH/NHLBI
“Measuring Lung Stress to Identify Occult Ventilation-Induced Lung Injury in ARDS” |
|
|
|
| Dr. Elana Bernstein |
|
|
5-year Mentored Patient-Oriented Research Career Development Award (K23), NIH/NIAMS
“Screening Chest CT to Detect Interstitial Lung Disease in Systemic Sclerosis” |
|
|
|
| Drs. Jahar Bhattacharya [Multiple PI award with Dr. Donna Farber (Dept. of Surgery)] |
|
|
4-year cooperative agreement, NIH/NHLBI
“Immunobiology and Alveolar Physiology of the Aging Lung” |
|
|
|
| Dr. William Blaner [Multiple PI award with Dr. Marcin Golczak (Case Western Reserve University)] |
|
|
4-year new R01, NIH/NIDDK
“RBP2 Biology and Pathobiology” |
|
|
|
| Drs. Remi Creusot and Magdalena Bogun |
|
|
Translational Therapeutics Accelerator (TRx) Pilot Award, Irving Institute for Clinical and Translational Research
“Preclinical Optimization of DNA and mRNA-based Endotope Platforms” |
|
|
|
| Dr. Matthew Cummings [mentors; Drs. Max O'Donnell, W. Ian Lipkin (Mailman SPH), and Patrick Wilson (Dept. of Pediatrics)] |
|
|
2-year Early Career Award, Thrasher Research Fund
“Precision Detection and Characterization of Pediatric Severe Acute Respiratory Infection in Uganda” |
|
|
(mentor: Dr. Max O’Donnell)
2 year Individual Postdoctoral Fellowship (F32), NIH/NIAID
“Phenotyping Sepsis in Uganda Using Molecular Pathogen Diagnostics and Latent Class Modeling”
Research grant, Potts Memorial Foundation
"Leveraging Novel Molecular Diagnostics to Enhance Detection of Mycobacteroium tuberculosis-Associated Sepsis in Uganda” |
|
|
|
| Dr. Matthew Dallos (mentor: Dr. Charles Drake) |
|
|
1-year Choose Chicago Young Investigator Award, American Society of Clinical Oncology (ASCO)/Conquer Cancer Foundation
“Maximizing Androgen Deprivation Immunogenicity through PD-1 and IL-8 Blockade in Castration-Sensitive Prostate Cancer” |
|
|
Young Investigator Award, Prostate Cancer Foundation
“Combining Treg Depletion with Androgen Deprivation in the Neo-Adjuvant Setting” |
|
|
|
| Drs. Changchun Deng and Jennifer Lue |
|
|
Translational Therapeutics Accelerator (TRx) Pilot Award, Irving Institute for Clinical and Translational Research
“Developing PI3 Kinase Inhibitors for T Cell Lymphoma” |
|
|
|
| Dr. Emily DiMango |
|
|
3-year award, Cystic Fibrosis Foundation
Vice Chair/ Chair of TDN Protocol Review Committee |
|
|
1-year Airways Clinical Research Centers Network Award, American Lung Association |
|
|
1-year Center Award, Cystic Fibrosis Foundation |
|
|
|
| Dr. Charles Drake |
|
|
2-year Challenge Award, Prostate Cancer Foundation
“Maximizing Androgen Deprivation ImmunoGenICity with PD-1 and IL-8 blockade in Lethal Prostate Cancer (MAGIC-8)” |
|
|
|
| Dr. Rebuma Fite (mentor: Dr. Remi Creusot) |
|
|
3-year Postdoctoral Minority Fellowship Award, American Diabetes Association
“Re-Establishing Immune Tolerance Against Multiple β Cell Antigens Using Novel Epitope Delivery Approaches” |
|
|
|
| Dr. Daniel Freedberg |
|
|
4-year Clinical Trial Award, Dept. of Defense/Congressionally Directed Medical Research Programs (CDMRP) Peer Reviewed Medical Research Program (PRMRP)
“Prebiotic Inulin to Limit Antimicrobial-Resistant Infections During Critical Illness: A Phase II Clinical Trial” |
|
|
|
| Dr. Jianing Fu |
|
|
Discovery Award, DoD/CDMRP Peer Reviewed Medical Research Program (PRMRP)
“Single-Cell Immune Profiling of Alloreactive T Cells Locally and Systemically in Patients Receiving Intestinal Transplantation” |
|
|
|
| Ms. Molly Gallop (mentor: Dr. Anthony Ferrante) |
|
|
2-year Individual Pre-Doctoral Fellowship (F31), NIDDK
“Overfeeding and Body Weight Regulation” |
|
|
|
| Dr. Yevgeniya (Jenny) Gartshteyn (mentors: Drs. Anca Askanase and Daichi Shimbo) |
|
|
Daland Fellowship in Clinical Investigation, American Philosophical Society
“PC4d as a Possible Biomarker for Accelerated Atherosclerosis in Systemic Lupus Erythematosus (SLE)” |
|
|
|
| Dr. Christian Geier (mentor: Dr. Robert Winchester) |
|
|
2-year Mandl Connective Tissue Research Fellowship, CUIMC
“Do Inflammatory Dendritic Cells Drive Connective Tissue Injury in Rheumatoid Arthritis?” |
|
|
|
| Dr. Ali Gharavi |
|
|
5-year cooperative agreement competitive renewal, NIH/NIDDK
“The Columbia PCC for CureGN: the Cure Glomerulonephropathy network” |
|
|
|
| Drs. Ali Gharavi and Jonathan Barasch [Multiple PI award with Dr. Cathy Mendelsohn (Dept. of Urology)] |
|
|
2-year cooperative agreement center award (U54), NIH/NIDDK
“Investigating the Genetic, Cellular, and Metabolic Events Important for Urothelial Homeostasis and Response to Urinary Tract Infection” |
|
|
|
| Dr. Arnold Han |
|
|
2-year Small Grant (R03), NIDDK
“Cytotoxic T cells in Ulcerative Colitis” |
|
|
Young Physician-Scientist Award, American Society for Clinical Investigation |
|
|
|
| Dr. Jessica Hawley (mentors: Drs. Charles Drake and Mark Stein) |
|
|
1-year Bristol-Myers Squibb Endowed Women Who Conquer Cancer Young Investigator Award, American Society of Clinical Oncology (ASCO)/Conquer Cancer Foundation
“Augmenting the ADT-Induced Immune Infiltrate in Metastatic Hormone-Sensitive Prostate Cancer with PD-1 Blockade and Docetaxel" |
|
|
|
| Dr. Dawn Hershman |
|
|
1-year research grant, Breast Cancer Research Foundation
“Interventions to Reduce Therapy Related Adverse Effects” |
|
|
6-year cooperative agreement competitive renewal, NIH/NCI
[Multiple PI award with Drs. Charles Blanke (Oregon Health & Science University) and Catherine Tangen (Fred Hutchinson Cancer Research Center)]
“SWOG NCORP Research Base” |
|
|
|
| Dr. Jaime Hook |
|
|
Grant-In-Aid, Stony Wold-Herbert Fund
“Neutrophic-Epithelial Interactions in Repair of MRSA-Induced Lung Alveolar Damage” |
|
|
|
| Dr. Matthew Ingham |
|
|
3-year Career Development Award, ASCO/Conquer Cancer Foundation/Sarcoma Foundation of America
"A Phase II Study of the PARP Inhibitor Olaparib in Combination with the DNA Damaging Agent Temozolomide for the Treatment of Advanced Uterine Leiomyosarcoma" |
|
|
|
| Dr. Benjamin Izar |
|
|
5-year Career Awards for Medical Scientists, Burroughs Wellcome Fund
“Functional Validation of Resistance Mechanisms to Immunotherapies at Single-Cell Resolution” |
|
|
|
| Dr. Kevin Kalinsky |
|
|
SWOG Career Engagement Award, The Hope Foundation for Cancer Research
“Circulating Biomarker Assessment for Late Relapse in Patients with Node Positive, Hormone Receptor Positive, HER2 Negative Operable Breast Cancer” |
|
|
1-year Research Grant, Breast Cancer Research Foundation
“Circulating Biomarker Determinants of Late Relapse” |
|
|
|
| Dr. Claire Keating |
|
|
|
2-year Therapeutics Development Center (TDN) Principle Investigator Protected Effort (PIPE) award, Cystic Fibrosis Foundation |
|
|
|
| Dr. Leila Khalili (mentor: Anca D. Askanase) |
|
|
| 1-year Mentored Nurse Practitioner/Physician Assistant Award for Workforce Expansion, Rheumatology Research Foundation |
|
|
|
|
Dr. John Kim (mentor: Dr. David Lederer) |
|
|
Grant-In-Aid, Stony Wold-Herbert Fund
“Role of Polyunsaturated Fatty Aids in Pulmonary Fibrosis" |
|
|
|
| Dr. Krzysztof Kiryluk [Multiple PI award with Dr. Shuang Wang (Dept. of Biostatistics) and Dr. Chunhua Weng (Dept. of Biomedical Informatics) |
|
|
5-year new R01, NIH/NLM
“Big Data Methods for Comprehensive Similarity Based Risk Prediction” |
|
|
|
| Dr. Jonathan Kochav |
|
|
Glorney-Raisbeck Fellowship in Cardiovascular Diseases, New York Academy of Medicine
“Impact of Papillary-Ventricular Ischemia on Functional Mitral Regurgitation - Integrated Tissue and Strain Based Assessment via Cardiac Magnetic Resonance” |
|
|
|
| Drs. Ian Kronish and Don Edmondson |
|
|
5-year Center Grant (P30), NIH/NIA
“Columbia Roybal Center for Fearless Behavior Change” |
|
|
|
| Dr. Jared Kushner |
|
|
Glorney-Raisbeck Junior Faculty Research Award, New York Academy of Medicine
“Prevention of Arrhythmia through Disruption of CaV1.2 alpha-beta Subunit Interaction” |
|
|
|
| Dr. Bahar Laderian (mentor: Dr. Antonio Fojo) |
|
|
1-year Merck & Co., Inc. Young Investigator Award, American Society of Clinical Oncology (ASCO)/Conquer Cancer Foundation
“Toward a Better Understanding of a Rare Cancer: Studies to Explore the Etiology and Biology of SDHx-Associated Pheochromocytomas and Paragangliomas” |
|
|
|
| Dr. Benjamin Lebwohl |
|
|
3-year research grant, Celiac Disease Foundation
“Microbiome and Population-Based Outcomes Research in Celiac Disease” |
|
|
|
| Dr. Siyang Leng |
|
|
Donald C. Brockman Memorial Research Grant, Amyloidosis Foundation
“Quality of Care and Disparities in Myeloma-Associated Amyloidosis” |
|
|
|
| Dr. Suzanne Lentzsch |
|
|
2-year Clinic and Laboratory Integration Program (CLIP) Grant, Cancer Research Institute
“Checkpoint Inhibitor PD-1H (VISTA) Links Multiple Myeloma Bone Disease and Myeloma Induced Immunosuppression” |
|
|
|
| Dr. Matthew Lewis |
|
|
2-year research grant, Adult Congenital Heart Association
“Patient Centered Research Models to Diagnose and Treat Anxiety Disorders in Adult Congenital Heart Disease: A Pilot Pragmatic Clinical Trial” |
|
|
|
| Dr. Yuxuan Liu (mentor: Dr. Jennifer Amengual) |
|
|
Postdoctoral Fellowship Grant, Lymphoma Research Foundation
“Development of First-in-Class Histone Acetyltransferase (HAT) Activators” |
|
|
|
| Dr. Jose Luchsinger |
|
|
[Multiple PI award with Drs. Davangere Devanand (Dept. of Neurology) and Ashwini Rao (Dept. of Rehabilitation and Regenerative Medicine)]
1-year High Priority, Short Term Project Award (R56), NIH/NIA
“Auditory, Olfactory, and Motor Correlates of in-vivo AD Neuropathology and Cognitive Decline in Late-Middle Age”
5-year new R01, NIH/NIA
“Metformin in Alzheimer's dementia Prevention (MAP)” |
|
|
|
| Dr. Nour Makarem |
|
|
3-year Career Development Award, American Heart Association
“Circadian Pattern of Rest-Activity Rhythms and Blood Pressure and the Underlying Epigenetic Mechanisms” |
|
|
5-year Pathway to Independence Award (K99/R00), NIH/NHLBI
“Circadian Pattern of Rest-Activity Rhythms and Blood Pressure and the Underlying Epigenetic Mechanisms” |
|
|
|
| Dr. Mathew Maurer [Multiple PI award with Dr. Frederick Ruberg (Boston Medical Center)] |
|
|
5-year R01, NIH/NHLBI
“SCAN-MP (Screening for Cardiac Amyloidosis with Nuclear imaging in Minority Populations)” |
|
|
|
| Dr. Jeremiah Martino [mentor: Dr. Simone Sanna-Cherchi, co-mentor: Dr. Cathy Mendelsohn (Dept. of Urology)] |
|
|
3-year individual Postdoctoral Fellowship (F32), NIDDK
“Genetic and Molecular Etiology of Developmental Kidney and Urinary Tract Abnormalities in the DiGeorge, or 22q11.2, Syndrome” |
|
|
|
| Dr. Steven Marx [Multiple PI award with Dr. Geoffrey Pitt (Weill Cornell Medical College)] |
|
|
4-year new R01, NIH/NHLBI
“Phosphorylation-Dependent Regulation of Calcium Channels by Macromolecular Complexes” |
|
|
|
| Dr. Wendy McKimpson |
|
|
4-year Mentored Research Scientist Development Award (K01), NIH/NIDDK
“Gut Cell Plasticity During Diabetes Treatment” |
|
|
|
| Dr. Sumit Mohan [Multiple PI award with Dr. James Dubois (Washington University)] |
|
|
3-year new R01, NH/NIMHD
“Identifying and Exploring Solutions to the Ethical Challenges of ApoL1 Testing of Donors with Recent African Ancestry through Mixed Methods Research with Stakeholders” |
|
|
|
| Dr. Nathalie Moise |
|
|
3-year Florence and Herbert Irving Clinical Research Career Award (“Irving Scholars”), Irving Institute for Clinical and Translational Research
“Harnessing Precision Medicine and Implementation Science to Improve Psychological Distress Treatment in Breast Cancer Patients” |
|
|
|
| Dr. Adam Mor |
|
|
2-year research grant, Emerson Collective Cancer Research Fund
“Mechanistic Markers for the Onset of Immune-Related Adverse Events Associated with PD-1 Blockade” |
|
|
2-year Technology Impact Award, Cancer Research Institute
“Novel Technology to Discover Targetable Kinases to Enhance Checkpoints Inhibition” |
|
|
2-year Exploratory/Developmental Research Grant (R21), NIH/NCI
“(PQ8) Predictive Biomarkers for the Onset of Immune-Related Adverse Events Associated with PD-1 Blockade” |
|
|
|
| Dr. Andrew Moran [Multiple PI award with Dr. Sarah De Ferranti (Boston Children’s Hospital) |
|
|
4-year new R01, NIH/NHLBI
“Familial Hypercholesterolemia Screening in Children: Population Impact of Phenotype, Genotype, and Cascade Approaches” |
|
|
|
| Dr. Munemasa Mori |
|
|
4-year new R01, NIH/NHLBI
“Regulatory Mechanisms of Cell Competition in Lung Regeneration” |
|
|
|
| Dr. Youngji Na |
|
|
Mentored Research Scientist Development Award (K01), NIH/NIDDK
“Rare Variant Analysis of Glomerulonephritis” |
|
|
|
| Dr. Lale Ozcan |
|
|
Journal of Lipid Research (JLR) Junior Investigator Award, Kern Lipid Meeting
“Regulation of PCSK9 and LDLc by Glucagon Signaling” |
|
|
|
| Dr. Owen O'Connor |
|
|
3-year Translational Research Program Grant, Leukemia & Lymphoma Society
“Translating Novel Immunoepigenetic Concepts to the Treatment of T -Cell Lymphomas (TCL)” |
|
|
|
| Dr. Utpal Pajvani |
|
|
4-year new R01, NIH/NIDDK
“Jagged-Notch signaling in NASH/Fibrosis” |
|
|
|
| Dr. Priya Palta |
|
|
5-year R01, NIH/NIA
“Blood Pressure and ADRD in African Americans: the Jackson Heart Study” |
|
|
|
| Dr. Huize Pan (mentor: Dr. Muredach Reilly) |
|
|
2-year Postdoctoral Fellowship, American Heart Association
“Human VSMC Mechanisms of Action of ADAMTS7 Locus for CAD” |
|
|
|
| Dr. Megha Prasad |
|
|
| Women in Innovations (WIN) Complex and High-risk Interventional Procedures (CHIP) Fellowship, Society for Cardiovascular Angiography and Interventions |
|
|
|
| Dr. Vikram Premkumar (mentor: Dr. Suzanne Lentzsch) |
|
|
1-year AstraZeneca Young Investigator Award, American Society of Clinical Oncology (ASCO)/Conquer Cancer Foundation
“Identifying the Role of Programmed Death-1 Homolog (PD-1H) on Osteoclast Signaling and Activation within the Bony Microenvironment in Multiple Myeloma Bone Disease” |
|
|
|
| Dr. Jianwen Que |
|
|
4-year R01 competitive renewal, NIH/NIDDK
“Basal Progenitor Cells and Eosinophilic Esophagitis” |
|
|
4-year new R01, NIH/NIDDK
“Signaling Mechanisms Promoting Barrett’s Metaplasia” |
|
|
|
| Dr. Alexander Raufi (mentor: Dr. Gulam Manji) |
|
|
1-year Young Investigator Award, American Society of Clinical Oncology (ASCO)/Conquer Cancer Foundation
“A Phase II Study of Chemotherapy and Immune Checkpoint Blockade with Pembrolizumab in the Perioperative and Maintenance Treatment of Locoregional Gastric and Gastroesophageal Junction Adenocarcinoma” |
|
|
|
| Dr. Azra Raza |
|
|
1-year Research Grant, Cures Within Reach
“Cellular and Molecular Basis of Anemia in Refractory Anemia with Ring Sideroblasts” |
|
|
|
| Dr. Ran Reshef |
|
|
2-year Idea Award, Dept. of Defense/Congressionally Directed Medical Research Programs (CDMRP) Peer Reviewed Cancer Research Program (PRCRP)
“Glucagon-Like-Peptide 2 (GLP-2) Analogues as a Novel Strategy for Prevention and Treatment of Graft-Versus-Host Disease” |
|
|
5-year new R01, NIH/NHLBI
“Effector T-Cell Trafficking in Graft-Versus-Host Disease” |
|
|
|
| Dr. Michaela Restivo Anderson |
|
|
Grant-In-Aid, Stony Wold-Herbert Fund
“Prospective Study of Subcutaneous Adipose Tissue and Risk of Acute Respiratory Distress
Syndrome in Moderate to Severe Pneumonia” |
|
|
|
| Dr. Gissette Reyes-Soffer |
|
|
Provost’s Grants Program for Junior Faculty Who Contribute to the Diversity Goals of the University, Columbia University
“Deep Phenotyping of Lipoprotein (a): An Emerging Risk Factor for Cardiovascular Disease” |
|
|
3-year Florence and Herbert Irving Clinical Research Career Award (“Irving Scholars”), Irving Institute for Clinical and Translational Research
“Unraveling the Complexities of Lipoprotein(a) in Humans Through Stable Isotope Metabolic Studies, Proteomics, and Particle Characterization” |
|
|
|
| Daniel Roybal (mentor: Dr. Steven Marx) |
|
|
3-year Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research, NIH/NHLBI
“Signaling Pathways and Regulators of Calcium Channels in Heart” |
|
|
|
| Dr. Mishaela Rubin |
|
|
5-year new R01, NIH/NIDDK
“Skeletal Fragility in Type 1 Diabetes: Glycemic Control and Bone Strength” |
|
|
|
| Dr. Yvonne Saenger [Multiple PI award with Dr. John Krolewski (Roswell Park Comprehensive Cancer Center)] |
|
|
2-year new cooperative agreement, NIH/NCI
“A Prognostic mRNA Immune Signature for Resected Stage II-III Melanoma” |
|
|
|
| Dr. Robert Schwabe |
|
|
4-year new R01, NIH/NIDDK
“DAMPs and Their Receptors Link Hepatocyte Death to HSC Activation and Liver Fibrosis” |
|
|
|
| Drs. Gary Schwartz [with Dr. Andrea Califano (Dept. of Systems Biology)] |
|
|
Translational Therapeutics Accelerator (TRx) Pilot Award, Irving Institute for Clinical and Translational Research
“Validating OncoTreat, a Systems Biology Approach to Predict Drug Sensitivity, in Advanced Gastrointestinal Stromal Tumors” |
|
|
|
| Drs. Gary Schwartz and Al Neugut [Multiple PI award with Dr. Andrew Lassman (Dept. of Neurology)] |
|
|
6-year cooperative agreement competitive renewal, NIH/NCI
“Columbia University Minority/Underserved Site NCI Community Oncology Research Program” |
|
|
|
| Dr. Michael Shen |
|
|
5-year new R01, NIH/NCI
“Analysis of Epithelial Heterogeneity in Prostate Development and Cancer” |
|
|
|
| Dr. Yuichi Shimada |
|
|
Precision Medicine Pilot Award, Irving Institute for Clinical and Translational Research
"Application of Multi-omics Profiling to Predict Adverse Left Ventricular Remodeling and Cardiovascular Events in Hypertrophic Cardiomyopathy" |
|
|
|
| Dr. Jennifer Small-Saunders (mentor: Dr. David Fidock) |
|
|
2-year Physician Scientist Fellowship, Doris Duke Charitable Foundation
“Programming tRNA Modifications in the Human Malaria Parasite Plasmodium falciparum: A New Paradigm for Artemisinin Resistance in Asian Isolates” |
|
|
|
| Dr. Hans-Willem Snoeck |
|
|
4-year new R01, NIH/NHLBI
“Lung Epithelial Cell Specification in Human Pluripotent Stem Cells” |
|
|
|
| Dr. Megan Sykes |
|
|
New 2-year Exploratory/Developmental Research Grant (R21), NIH/NIAD
"Thymic Negative Selection in Human T1D Immune Systems" |
|
|
[Multiple PI award with Drs. Mark Anderson, Matthias Hebrok, and Audrey Parent (UC San Francisco)]
4-year cooperative agreement (U01), NIH/NIDDK
“Modeling Autoimmune Pathogenesis and Beta Cell Destruction by T1D Immune Systems” |
|
|
|
| Dr. Ira Tabas |
|
|
7-year Outstanding Investigator Award (R35), NIH/NHLBI
“A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques” |
|
|
|
| Drs. Alan Tall and Ira Tabas |
|
|
Transatlantic Networks of Excellence, Leducq Foundation for Cardiovascular Research
“Clonal Hematopoiesis and Atherosclerosis” |
|
|
|
| Dr. Alan Tall |
|
|
4-year R01 competitive renewal, NIH/NHLBI
“ABCA1/G1 and LXRs in Atherogenesis” |
|
|
|
| Dr. Veli Topkara |
|
|
4-year Mentored Clinical Scientist Research Career Development Award (K08), NIH/NHLBI
“Defining the Role of lnc-TECRL in Maladaptive Cardiac Remodeling” |
|
|
|
| Dr. Meghna Trivedi |
|
|
Dr. Charles A. Coltman, Jr. Fellowship Award, Hope Foundation for Cancer Research
“A Prospective Observational Cohort Study to Develop a Predictive Model of Taxane-Induced Peripheral Neuropathy in Cancer Patients” |
|
|
|
| Dr. Emily Tsai |
|
|
3-year Florence and Herbert Irving Clinical Research Career Award (“Irving Scholars”), Irving Institute for Clinical and Translational Research
“Validation and Translation of a Novel Transcriptomic Signature of Right Ventricular Failure” |
|
|
|
| Dr. Miguel Verbitsky |
|
|
2-year Exploratory/Developmental Research Grant (R21), NIH/NIDDK
“Investigation of Genomic Disorders in Chronic Kidney Disease” |
|
|
|
| Dr. Elaine Wan |
|
|
2-year Small Grant (R03), NHLBI
“Elucidating the Molecular Mechanisms of Cognitive Decline in Atrial Fibrillation” |
|
|
1-year research grant, Saving tiny Hearts Society
“Understanding Cardiac Arrhythmias in Congenital Heart Disease Using a Novel 3D Panoramic Optical Mapping System” |
|
|
|
| Dr. Liheng Wang |
|
|
5-year Mentored Research Scientist Development Award (K01), NIH/NIDDK
“TOX4 Integrates Hormone Signaling on Hepatic Glucose and Lipid Metabolism” |
|
|
|
| Dr. Nan Wang |
|
|
4-year new R01, NIH/NHLBI
“JAK2V617F, Clonal Hematopoiesis and Atherosclerosis” |
|
|
|
| Dr. Runsheng Wang |
|
|
Career Development Bridge Funding Award, Rheumatology Research Foundation
“Comparative Effectiveness Research in Axial Spondyloarthritis” |
|
|
|
| Dr. Tim Wang |
|
|
[Multiple PI award with Dr. Chandan Guha (Albert Einstein College of Medicine)]
5-year cooperative agreement, NIH/NIDDK
“Understanding Stem Cell Heterogeneity and Niche Function in Intestinal Regeneration after Irradiation” |
|
|
|
| Drs. Timothy Wang and Don Landry |
|
|
Translational Therapeutics Accelerator (TRx) Pilot Award, Irving Institute for Clinical and Translational Research
“Development of a Novel Beta2-blocker for Treating Pancreatic Cancer” |
|
|
|
| Dr. Timothy Wang |
|
|
5-year training grant (T32) competitive renewal, NIH/NIDDK
“Multidisciplinary Training in Translational Gastrinointestinal and Liver Research” |
|
|
|
| Dr. Robert Winchester |
|
|
3-year Transformational Project Award, American Heart Association
“Identification of Immunological Mechanisms Targeting the Myocardium in Rheumatoid Arthritis” |
|
|
|
| Dr. Kryscilla Yang (mentor: Sykes, Megan) |
|
|
1-year Basic Science Fellowship Research Grant, American Society of Transplantation
“T-Cell Receptor Deep Sequencing to Distinguish Autoimmune Recurrence from Allograft Rejection in Liver Transplant Patients with Autoimmune Liver Disease” |
|
|
|
| Dr. Michael Yin |
|
|
Integrating Special Populations (ISP) Pilot Award, Irving Institute for Clinical and Translational Research
“Psychosocial Stressors and Ambulatory Blood Pressure in Young Adults with Perinatal-Acquired HIV” |
|
|
|
| Dr. Sunmoo Yoon |
|
|
5-year new R01, NIH/NIA
“Using Twitter to Enhance the Social Support of Hispanic and Black Dementia Caregivers (Tweet-SS)” |
|
|
|
| Dr. Arif Yurdagul |
|
|
5-year Pathway to Independence Award (K99/R00), NIH/NHLBI
“Processing of Apoptotic Cell-Derived Cargo by Macrophages Continues Efferocytosis and Drives Atherosclerosis Regression” |
|
|
|
| Dr. Ze Zheng (mentor: Ira Tabas) |
|
|
2-year Fellow Scholar Award, American Society of Hematology
“Obesity-Associated Thrombosis: Role of Reduced Hepatocyte-Derived Fibrinolytic Activity” |
|
|
3-year Career Development Award, American Heart Association
“Role of Reduced Hepatocyte-Derived tPA Activity in Obesity-Associated Atherothrombosis” |
|
|
|